Product Information

CARBIDOPA-LEVODOPA 10-100 TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.0663 per EA under NDC 72888010605. Its NADAC has been published 174 times since Jul 26, 2023.

FDA first approved this application on Sep 21, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARBIDOPA-LEVODOPA 10-100 TAB

carbidopa and levodopa
$0.0663per EA

Strength

10; 100 mg/1; mg/1

NDC

72888010605

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CARBIDOPA; LEVODOPA

Approval Type

Generic (ANDA)

FDA Application

ANDA216505

FDA Approved

9/21/2022

TE Code

AB

On Market Since

9/21/2022

Pharmacological Classes

Amino Acids
Aromatic
Aromatic Amino Acid

Price Statistics

The NADAC for CARBIDOPA-LEVODOPA 10-100 TAB has been published 174 times since Jul 26, 2023, and over the history we have for it it has declined 48.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0663 per EA
All-time high$0.1279 (Aug 16, 2023)
All-time low$0.0637 (Jul 22, 2026)
52-week high$0.0925
52-week low$0.0637
Median price$0.0915
Average price$0.0930
Largest weekly change-28.9% (Apr 17, 2024)
Weeks tracked174
Tracking sinceJul 26, 2023

Price History

1W

-10.6%

1M

-2.9%

3M

-1.8%

6M

-20.4%

1Y

-21.2%

3Y

-38.0%

5Y

N/A

All

-48.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CARBIDOPA-LEVODOPA 10-100 TAB?

The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 10-100 TAB, manufactured by Advagen Pharma Ltd., is $0.0663 per EA (NDC 72888010605), effective Nov 18, 2026.

How has the price of CARBIDOPA-LEVODOPA 10-100 TAB changed over time?

Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 10-100 TAB has declined 48.2%. It has been tracked across 174 weekly CMS publications since Jul 26, 2023.

What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 10-100 TAB?

Since Jul 26, 2023, the NADAC for CARBIDOPA-LEVODOPA 10-100 TAB has ranged from a low of $0.0637 (Jul 22, 2026) to a high of $0.1279 (Aug 16, 2023), with a median of $0.0915 per EA.

Are there cheaper alternatives to CARBIDOPA-LEVODOPA 10-100 TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARBIDOPA-LEVODOPA 10-100 TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures CARBIDOPA-LEVODOPA 10-100 TAB?

CARBIDOPA-LEVODOPA 10-100 TAB (NDC 72888010605) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.